In particular, a previous study proposed a T cell gene expression panel including the OAS2, CD70, and IL10 genes as useful biomarkers for SLE discrimination from other autoimmune diseases and for the monitoring of disease activity [15]. This evidence concerns the gene CD70 and systemic lupus erythematosus.